LLY

Eli Lilly and Company

78
Fundamentals85/ 100
Valuation62/ 100
Upside potential72/ 100
Risk potential15/ 100

LLY has the edge over NET overall, supported by stronger fundamentals and lower modeled downside.

NET

Cloudflare, Inc.

62
Fundamentals60/ 100
Valuation50/ 100
Upside potential63/ 100
Risk potential32/ 100

NET's outlook is improving, though it still trails on the overall score.

LLY Fundamentals

MetricStatus
Healthy
Strong
Strong
Healthy

LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.

NET Fundamentals

MetricStatus
Strong
Weak
Strong
Unavailable

NET's revenue and cash flow are currently strong, but its profitability is weak. There isn't enough data to rate its balance sheet.

LLY PE Valuation

CHEAPFAIREXPENSIVE37x74x111x147x
CHEAPFAIREXPENSIVE37x74x111x147x
LevelPEPriceVs current
Cheap27x$845-41%
Forward30x$1,427—
Current46x$1,427—
Fair48x$1,466+2.7%
Expensive85x$2,612+83%

Historical ranges are pointers, not guarantees.

LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.

NET PE Valuation

NET has no meaningful PE right now: it lost money over the past year.

LLY Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for LLY, with profitability improving.

NET Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Strongly improving
Moderate
Low

Analysts expect strong earnings and revenue growth for NET, with profitability improving. However, they disagree widely on these estimates.

LLY Risk to reward

ScenarioChangePrice
Upside+39%$1,988.49
Downside-15%$1,209.08

Calculated from the latest close: $1,427.28 on Nov 12.

LLY has a better modeled risk to reward balance than NET, with more potential upside relative to its potential downside.

NET Risk to reward

ScenarioChangePrice
Upside+54%$489.89
Downside-32%$215.91

Calculated from the latest close: $318.50 on Nov 12.

NET trails LLY on modeled risk to reward, with less potential upside relative to its potential downside.

LLY Earnings Per Share

Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
QuarterTTM EPSYoY
Forward$46.82+52%
Q3 2026$30.81+51%
Q2 2026$29.80+95%
Q1 2026$28.15+129%
Q4 2025$22.95+96%
Q3 2025$20.44+121%
Q2 2025$15.30+88%
Q1 2025$12.29+81%
Q4 2024$11.71+102%

LLY has the edge over NET on earnings quality, reporting a profit while its opponent remains loss making.

NET Earnings Per Share

Q4 2023: $-0.55Q1 2024: $-0.53Q2 2024: $-0.29Q3 2024: $-0.26Q4 2024: $-0.23Q1 2025: $-0.24Q2 2025: $-0.35Q3 2025: $-0.31Q4 2025: $-0.29Q1 2026: $-0.25Q2 2026: $-0.58Q3 2026: $-0.68Forward: $1.75
Q4 2023: $-0.55Q1 2024: $-0.53Q2 2024: $-0.29Q3 2024: $-0.26Q4 2024: $-0.23Q1 2025: $-0.24Q2 2025: $-0.35Q3 2025: $-0.31Q4 2025: $-0.29Q1 2026: $-0.25Q2 2026: $-0.58Q3 2026: $-0.68Forward: $1.75
QuarterTTM EPSYoY
Forward$1.75—
Q3 2026-$0.68-$0.37
Q2 2026-$0.58-$0.23
Q1 2026-$0.25-$0.01
Q4 2025-$0.29-$0.06
Q3 2025-$0.31-$0.05
Q2 2025-$0.35-$0.06
Q1 2025-$0.24+$0.29
Q4 2024-$0.23+$0.32

NET is still losing money, but less than at its worst: $0.68 per share over the past year, against $0.91 at its worst in mid-2022.

LLY Quarterly Revenue

Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
QuarterRevenueYoY
Q3 2026$24.4B+39%
Q2 2026$23B+48%
Q1 2026$19.8B+56%
Q4 2025$19.3B+43%
Q3 2025$17.6B+54%
Q2 2025$15.6B+38%
Q1 2025$12.7B+45%
Q4 2024$13.5B+45%

LLY has the edge over NET on sales, with stronger typical year-over-year growth.

NET Quarterly Revenue

Q4 2023: $362MQ1 2024: $379MQ2 2024: $401MQ3 2024: $430MQ4 2024: $460MQ1 2025: $479MQ2 2025: $512MQ3 2025: $562MQ4 2025: $615MQ1 2026: $640MQ2 2026: $696MQ3 2026: $783M
Q4 2023: $362MQ1 2024: $379MQ2 2024: $401MQ3 2024: $430MQ4 2024: $460MQ1 2025: $479MQ2 2025: $512MQ3 2025: $562MQ4 2025: $615MQ1 2026: $640MQ2 2026: $696MQ3 2026: $783M
QuarterRevenueYoY
Q3 2026$782.5M+39%
Q2 2026$696.1M+36%
Q1 2026$639.8M+34%
Q4 2025$614.5M+34%
Q3 2025$562M+31%
Q2 2025$512.3M+28%
Q1 2025$479.1M+27%
Q4 2024$459.9M+27%

NET's revenue has grown year over year every quarter since late 2020: $783M last quarter, up 39% from the same quarter a year ago.

LLY Free Cash Flow

Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
QuarterFree cash flowYoY
Q3 2026$8.2B+22%
Q2 2026$7.8B+458%
Q1 2026$3B+1826%
Q4 2025$677.9M-31%
Q3 2025$6.7B+186%
Q2 2025$1.4B+476%
Q1 2025$156.1M-13%
Q4 2024$977.8M+$2.4B

LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.

NET Free Cash Flow

Q4 2023: $55MQ1 2024: $42MQ2 2024: $45MQ3 2024: $55MQ4 2024: $54MQ1 2025: $60MQ2 2025: $40MQ3 2025: $82MQ4 2025: $105MQ1 2026: $93MQ2 2026: $68MQ3 2026: $94M
Q4 2023: $55MQ1 2024: $42MQ2 2024: $45MQ3 2024: $55MQ4 2024: $54MQ1 2025: $60MQ2 2025: $40MQ3 2025: $82MQ4 2025: $105MQ1 2026: $93MQ2 2026: $68MQ3 2026: $94M
QuarterFree cash flowYoY
Q3 2026$93.6M+13%
Q2 2026$67.6M+69%
Q1 2026$93.1M+55%
Q4 2025$105.2M+94%
Q3 2025$82.5M+51%
Q2 2025$39.9M-12%
Q1 2025$59.9M+44%
Q4 2024$54.2M-0.9%

NET generated $359M in free cash flow over the past year, up 52% from the year before.

LLY Total Shares

Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
PeriodChange %Net change
Quarterly0%-300K shares
1 year-0.6%-5.4M shares
3 years-0.7%-6.4M shares
5 years-1.9%-17.4M shares
Available history-4.5%-42.3M shares

LLY has the edge over NET on shareholder dilution, with a more favorable share count trend.

NET Total Shares

Q4 2023: 334MQ1 2024: 339MQ2 2024: 341MQ3 2024: 342MQ4 2024: 341MQ1 2025: 346MQ2 2025: 347MQ3 2025: 349MQ4 2025: 348MQ1 2026: 353MQ2 2026: 354MQ3 2026: 357M
Q4 2023: 334MQ1 2024: 339MQ2 2024: 341MQ3 2024: 342MQ4 2024: 341MQ1 2025: 346MQ2 2025: 347MQ3 2025: 349MQ4 2025: 348MQ1 2026: 353MQ2 2026: 354MQ3 2026: 357M
PeriodChange %Net change
Quarterly+0.8%+2.8M shares
1 year+2.2%+7.8M shares
3 years+6.7%+22.5M shares
5 years+14%+42.6M shares
Available history+144%+211M shares

NET has 357M diluted shares, up 2.2% from a year ago.

LLY Net Leverage

Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
QuarterNet LeverageStatus
Q3 20261.2xHealthy
Q2 20261.3xHealthy
Q1 20261.2xHealthy
Q4 20251.3xHealthy
Q3 20251.3xHealthy
Q2 20252.0xHealthy
Q1 20252.3xModerate
Q4 20242.1xModerate

LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.

NET Net Leverage

NET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

LLY Weekly Momentum

MetricValueStatus
RSI68.3Neutral
Stochastic84.1Overbought

LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).

NET Weekly Momentum

MetricValueStatus
RSI55.9Neutral
Stochastic37.6Neutral

NET's weekly RSI is 56 (neutral) and its Stochastic is 38 (neutral).

LLY PE vs Healthcare Sector

MetricLLYSector medianRelative
PE46x26x79% above
PE %482919 pts above

LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.

NET PE vs Technology Sector

NET has no meaningful PE right now: it lost money over the past year.

LLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1,279.412% above
20 week MA$1,218.817% above
50 week MA$1,102.229% above
100 week MA$954.150% above
200 week MA$797.579% above

LLY has the edge over NET on trend strength, trading above more of its moving averages.

NET Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$318.60% below
20 week MA$299.86.2% above
50 week MA$241.032% above
100 week MA$204.955% above
200 week MA$139.8128% above

NET's trend is up, with a small recent dip: it's below only its 8-week average, and 128% above its 200-week average.

LLY Yearly ROI

YearStart priceEnd priceROI
2020$131.5$166.7+27%
2021$166.7$273.1+64%
2022$273.1$367.9+35%
2023$367.9$582.9+58%
2024$582.9$783.2+34%
2025$783.2$1,077.8+38%
2026 YTD$1,077.8$1,427.3+32%

LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.

NET Yearly ROI

YearStart priceEnd priceROI
2020$16.7$85.0+409%
2021$85.0$137.3+62%
2022$137.3$43.8-68%
2023$43.8$83.3+90%
2024$83.3$110.6+33%
2025$110.6$202.4+83%
2026 YTD$202.4$318.5+57%

NET has the edge over LLY on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key